Dolezil D - Search Results

Year	Number of Results
2008	1
2009	4
2010	3
2012	4
2013	1
2015	2
2016	1
2017	1
2018	2
2019	2
2020	4
2021	2
2022	2
2024	1

1

Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.

Tepper S, Ashina M, Reuter U, Brandes JL, Doležil D, Silberstein S, Winner P, Leonardi D, Mikol D, Lenz R. Tepper S, et al. Among authors: dolezil d. Lancet Neurol. 2017 Jun;16(6):425-434. doi: 10.1016/S1474-4422(17)30083-2. Epub 2017 Apr 28. Lancet Neurol. 2017. PMID: 28460892 Clinical Trial.

2

Early Use of Erenumab vs Nonspecific Oral Migraine Preventives: The APPRAISE Randomized Clinical Trial.

Pozo-Rosich P, Dolezil D, Paemeleire K, Stepien A, Stude P, Snellman J, Arkuszewski M, Stites T, Ritter S, Lopez Lopez C, Maca J, Ferraris M, Gil-Gouveia R. Pozo-Rosich P, et al. Among authors: dolezil d. JAMA Neurol. 2024 May 1;81(5):461-470. doi: 10.1001/jamaneurol.2024.0368. JAMA Neurol. 2024. PMID: 38526461 Free PMC article. Clinical Trial.

3

Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study.

Pozo-Rosich P, Detke HC, Wang S, Doležil D, Li LQ, Aurora SK, Reuter U. Pozo-Rosich P, et al. Among authors: dolezil d. Curr Med Res Opin. 2022 May;38(5):731-742. doi: 10.1080/03007995.2022.2059975. Epub 2022 Apr 15. Curr Med Res Opin. 2022. PMID: 35392739 Clinical Trial.

4

Galcanezumab in Patients with Multiple Previous Migraine Preventive Medication Category Failures: Results from the Open-Label Period of the CONQUER Trial.

Reuter U, Lucas C, Dolezil D, Hand AL, Port MD, Nichols RM, Stroud C, Tockhorn-Heidenreich A, Detke HC. Reuter U, et al. Among authors: dolezil d. Adv Ther. 2021 Nov;38(11):5465-5483. doi: 10.1007/s12325-021-01911-7. Epub 2021 Sep 20. Adv Ther. 2021. PMID: 34542830 Free PMC article. Clinical Trial.

5

Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis.

Ashina M, Tepper SJ, Brandes JL, Reuter U, Boudreau GP, Weatherall M, Gantenbein AR, Doležil D, Klatt J, Wang A, Karanam AK, Cheng S, Mikol DD. Ashina M, et al. Among authors: dolezil d. Headache. 2022 May;62(5):624-633. doi: 10.1111/head.14313. Headache. 2022. PMID: 35593783 Free PMC article.

6

Physiotherapy as an immunoactive therapy? A pilot study.

Rasova K, Dolezil D, Kalistova H, Kucera P, Juzova O, Zimova D, Medova E, Jandova D, Tintera J, Ibrahim I, Zvara K, Bicikova M, Martinkova P. Rasova K, et al. Among authors: dolezil d. Neuro Endocrinol Lett. 2012;33(1):67-75. Neuro Endocrinol Lett. 2012. PMID: 22467115

7

A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention.

Ashina M, Doležil D, Bonner JH, Zhou L, Klatt J, Picard H, Mikol DD. Ashina M, et al. Among authors: dolezil d. Cephalalgia. 2021 Jan;41(1):33-44. doi: 10.1177/0333102420970889. Epub 2020 Nov 24. Cephalalgia. 2021. PMID: 33231489 Free PMC article. Clinical Trial.

8

Efficacy and safety of lacosamide in painful diabetic neuropathy.

Ziegler D, Hidvégi T, Gurieva I, Bongardt S, Freynhagen R, Sen D, Sommerville K; Lacosamide SP743 Study Group. Ziegler D, et al. Diabetes Care. 2010 Apr;33(4):839-41. doi: 10.2337/dc09-1578. Epub 2010 Jan 12. Diabetes Care. 2010. PMID: 20067958 Free PMC article. Clinical Trial.

9

Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.

Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT; DEFINE Study Investigators. Gold R, et al. N Engl J Med. 2012 Sep 20;367(12):1098-107. doi: 10.1056/NEJMoa1114287. N Engl J Med. 2012. PMID: 22992073 Free article. Clinical Trial.

10

Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.

Ashina M, Tepper S, Brandes JL, Reuter U, Boudreau G, Dolezil D, Cheng S, Zhang F, Lenz R, Klatt J, Mikol DD. Ashina M, et al. Among authors: dolezil d. Cephalalgia. 2018 Sep;38(10):1611-1621. doi: 10.1177/0333102418788347. Epub 2018 Jul 8. Cephalalgia. 2018. PMID: 29984601 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year